about
Standardized remission criteria in schizophrenia.Objective Measures of Behavior Manifestations in Adult ADHD and Differentiation from Participants with Bipolar II Disorder, Borderline Personality Disorder, Participants with Disconfirmed ADHD as Well as Normative ParticipantsPerformance-based measurement of functional disability in schizophrenia: a cross-national study in the United States and Sweden.The weighed core symptom scale and prediction of ADHD in adults - objective measures of remission and response to treatment with methylphenidate.Measuring adult Attention Deficit Hyperactivity Disorder using the Quantified Behavior Test Plus.The importance of cross-sectional remission in schizophrenia for long-term outcome: a clinical prospective study.Predicting real-world functional milestones in schizophrenia.Family burden and functional assessment in the Swedish CLIPS-study: do staff and relatives agree on individuals with psychotic disorders' functional status?Assessment of Distress and Quality of Life: A Comparison of Self-Assessments by Outpatients with a Schizopsychotic Illness and the Clinical Judgment of Nurses.Cognitive performance, symptom severity, and survival among patients with schizophrenia spectrum disorder: A prospective 15-year study.Verbal learning in schizopsychotic outpatients and healthy volunteers as a function of cognitive performance levels.Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta) in patients with schizophrenia.What could be learned from a decade with standardized remission criteria in schizophrenia spectrum disorders: An exploratory follow-up study.A functional comparison of patients with schizophrenia between the North and South of Europe.Remission and cognitive ability in a cohort of patients with schizophrenia.Culture as a predictor of resistance to change: a study of competing values in a psychiatric nursing context.SU42. Physical Fitness in Association With Cognitive Performance—Possible Marker of Short Lifetime Expectancy for Patients With Schizophrenia.SU31. Cognition in Schizophrenia a Comparison With Healthy Controls—Cognitive Ability and Its Influence on Functional Outcome.F116. CAN INSIGHT LEAD TO REMISSION - FOR PATIENTS WITH SCHIZOPHRENIA?F112. LESS SYMPTOMS IN SCHIZOPHRENIA – A RISK FACTOR FOR IMPAIRED INSIGHT OF FUNCTIONING?T112. TRADITIONAL RISK FACTORS NOT ENOUGH TO EXPLAIN THE SHORT LIFETIME EXPECTANCY IN PATIENTS WITH SCHIZOPHRENIA.Positive and negative affect in schizophrenia spectrum disorders: A forgotten dimension?The Impact of Repeated Assessments by Patients and Professionals: A 4-Year Follow-Up of a Population With SchizophreniaCorrelates of risk factors for reduced life expectancy in schizophrenia: Is it possible to develop a predictor profile?Experience of quality of life and attitude to care and treatment in patients with schizophrenia: Role of cross-sectional remissionRemission in schizophrenia: Applying recent consensus criteria to refine the conceptPsychometric properties of the burden inventory for relatives of persons with psychotic disturbances
P50
Q34486075-2ABC50D2-1E75-476E-8BD2-038E43125509Q36395883-EE341AA9-8B54-4758-B3AD-41F276BCED1BQ36885649-9AF2963B-AF73-4320-BD98-FD7E226B3287Q37289793-32B55F6F-251D-40FC-BE0E-A56695A6620BQ37320445-5C9A2DC7-0B4B-4378-8133-DBFCEAF22780Q37576744-F0F5B287-B29E-46DA-9405-998C12DF557CQ38861248-3AD0149C-1506-4D13-8B85-BCE12C2CBB73Q39779353-BD8B1A45-5A08-45BA-81D1-5D35F15ECA88Q40511397-6146338E-CBBD-448B-89BC-54D550F4CE8FQ40517909-FE374B4D-ABC9-4C03-B072-9E6DD87E7C6FQ42609642-973079D8-B9E9-4481-83E4-5CBC0DE95067Q45264342-6890F640-3614-4B9D-9E9B-D457038ED2A2Q50128934-6E8E7423-DC96-4094-85AC-9A4F8D7D194DQ51032773-BA15E32A-1C41-4F59-9DEF-306E4E29C132Q51979493-A74EBC96-A54E-4877-8847-CB2E9577E528Q53105468-55707D34-812D-4694-9869-C948B6839B59Q54157332-FC8451E4-934F-42A2-B5DD-F7DBBA31E735Q55035433-DF8AEDE6-0989-4382-BC58-68510699A18CQ55056774-CCBB66CD-34E8-49C5-8031-2203EBE2260AQ55165519-30C5AFF5-AE9E-4FE8-9D98-B53D489F2D75Q55343981-EA0EE403-7BA4-4220-A718-5319A6C2430FQ60636296-63C7AFB1-B8A6-4EEC-82CB-8985BF7345E5Q60636297-9C682A0A-B0AE-4F2E-849D-06C1FEC7B0B4Q60636299-B40C273D-F222-4EC7-868A-ACA5654798DDQ60636301-E1B0BE9C-7079-436D-A26F-9015EB02F094Q60636303-04C4B2E5-896D-4C32-BCE6-C97AD830E496Q83059547-1F7B25A5-7DF7-4612-A91B-3207160371B9
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lars Helldin
@ast
Lars Helldin
@en
Lars Helldin
@es
Lars Helldin
@nl
type
label
Lars Helldin
@ast
Lars Helldin
@en
Lars Helldin
@es
Lars Helldin
@nl
prefLabel
Lars Helldin
@ast
Lars Helldin
@en
Lars Helldin
@es
Lars Helldin
@nl
P106
P1153
22134600400
P31
P496
0000-0002-5989-2168